Press Releases

Hayward, CA, May 22, 2018 – OptiScan Biomedical Corporation, a developer of an innovative continuous monitoring system for use in the surgical intensive care unit (SICU), today announced [...]

OptiScan Biomedical’s OptiScanner® 5000 Receives 510(k) Clearance from US Food and Drug Administration for the First Inline Continuous Glucose Monitor in the SICU First-of-its-Kind Automated, [...]

Company Secures EU Certification for World’s First Non-Calibrated Automated System for Continuous Monitoring of Multiple Analytes in Critically Ill Patients   San Francisco, CA, January 9, [...]

Pivotal Trial to Build on Previous Positive Studies; Aims to Further Demonstrate Paradigm-Shifting Potential of Automated, Bedside Glucose Monitoring System in the ICU —   HAYWARD, Calif., [...]

Industry Thought-Leaders Highlight Paradigm-Shifting Potential of Automated, Bedside Glucose Monitoring System for Critically Ill Patients   BRUSSELS, Belgium, March 21, 2013 – OptiScan [...]

All Measurement Readings Demonstrate Sufficient Accuracy to Guide Clinical Treatment Decisions; Results Achieved in Most Severely Ill Patients —   BRUSSELS, March 21, 2012 – OptiScan [...]